Optimizing direct-acting antiviral treatment for hepatitis c virus through pharmacist interventions

• At: Glasgow (Scotland) (2018)
• Type: Poster
• Poster code: POS-HPS-031
• By: CHIEN, Wei-Hsuan (Cheng Hsin General Hospital)
• Co-author(s): Wei-Hsuan Chien
  You-Min Lu
  Hung-Chua Chang
  Chien-Ming Huang
  
• Abstract:

  Background

  Treatment for hepatitis C virus (HCV) has evolved dramatically since the approval of all-oral direct-acting antivirals (DAAs). DAAs are majorly metabolized by liver enzymes and influence the activity of cytochrome P450 (CYP) enzymes. In addition, DAAs are both substrates and inhibitors of drug transporters, which increases the likelihood

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login